Wolters Kluwer Unveils Plans for Medi-Span Expert AI to Advance Medication Intelligence for Digital Health

Core Insights - Wolters Kluwer has announced the launch of Medi-Span Expert AI, aimed at enhancing medication intelligence for digital health technology developers [1] - The new Model Context Protocol (MCP) will facilitate the integration of AI-ready, expert-curated medication data into third-party applications, streamlining development processes [1] Group 1: Product Development and Features - Medi-Span Expert AI is designed to support various AI-driven workflows, including prescription renewals and medication verification, which are identified as the fastest-growing segments in healthcare [1] - The MCP server connects expert-curated drug content to AI workflows, enabling faster innovation and reducing complexity for digital health tech developers [1] - The solution aims to improve patient safety by providing robust drug dosing guidelines and advanced decision-making logic [1] Group 2: Market Context and Demand - There is a rising demand for automation in medication management, with healthcare providers seeking more efficient and reliable systems [1] - Current integration standards for drug information are not optimized for AI workflows, which can hinder innovation in the sector [1] - Wolters Kluwer's Medi-Span Expert AI is positioned to address these challenges by offering a dynamic format for drug content that is ready for AI applications [1] Group 3: Company Overview - Wolters Kluwer reported annual revenues of €5.9 billion for 2024 and operates in over 180 countries, employing approximately 21,600 people [1] - The company specializes in providing information, software solutions, and services across various sectors, including healthcare and technology [1]